Factors Affecting Intensive Aflibercept Treatment Response in Diabetic Macular Edema: A Real-World Study
Objective. To investigate the systemic and ocular factors that affect the response to intensive aflibercept treatment in diabetic macular edema (DME) in a real-world setting. Methods. This retrospective cohort study evaluated 30 eyes of 23 patients with DME who underwent intensive intravitreal aflib...
Saved in:
| Main Authors: | Ye Eun Han, Jaehyuck Jo, Yoon Jeon Kim, Junyeop Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2023/1485059 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brolucizumab versus aflibercept for recalcitrant diabetic macular edema in Indian real-world scenario – The BRADIR study
by: Debdulal Chakraborty, et al.
Published: (2024-12-01) -
Effectiveness of aflibercept in treating bevacizumab resistant macular edema
by: Hussain Khudair Yassin
Published: (2024-12-01) -
Short-term outcomes of faricimab and aflibercept 8 mg in diabetic macular edema
by: Carlo Maccauro, et al.
Published: (2025-07-01) -
Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema
by: Gaixia Zhai, et al.
Published: (2025-03-01) -
Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema
by: Valérie Sarda, et al.
Published: (2020-01-01)